News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
438,344 Results
Type
Article (34771)
Company Profile (70)
Press Release (403503)
Section
Business (132940)
Career Advice (1533)
Deals (26117)
Drug Delivery (98)
Drug Development (62171)
Employer Resources (119)
FDA (10564)
Job Trends (9918)
News (236887)
Policy (26626)
Tag
Academia (1946)
Alliances (43329)
Alzheimer's disease (1075)
Approvals (10525)
Artificial intelligence (118)
Bankruptcy (254)
Best Places to Work (8269)
Breast cancer (156)
Cancer (1160)
Cardiovascular disease (85)
Career advice (1293)
CAR-T (84)
Cell therapy (234)
Clinical research (49492)
Collaboration (475)
Compensation (248)
COVID-19 (2493)
C-suite (92)
Data (1104)
Diabetes (163)
Diagnostics (3886)
Drug pricing (86)
Earnings (47863)
Employer resources (108)
Events (51269)
Executive appointments (324)
FDA (11140)
Funding (360)
Gene therapy (179)
GLP-1 (634)
Government (4150)
Healthcare (12623)
Infectious disease (2589)
Inflammatory bowel disease (85)
Interviews (250)
IPO (11356)
Job creations (1995)
Job search strategy (1118)
Layoffs (285)
Legal (7255)
Lung cancer (170)
Manufacturing (183)
Medical device (7067)
Medtech (7069)
Mergers & acquisitions (14954)
Metabolic disorders (457)
Neuroscience (1363)
NextGen: Class of 2025 (4200)
Non-profit (2991)
Northern California (1301)
Obesity (271)
Opinion (197)
Parkinson's disease (87)
Patents (100)
People (34460)
Phase I (15013)
Phase II (21570)
Phase III (17316)
Pipeline (498)
Postmarket research (1926)
Preclinical (6215)
Radiopharmaceuticals (218)
Rare diseases (221)
Real estate (2949)
Regulatory (16625)
Research institute (1709)
Resumes & cover letters (227)
Southern California (1040)
Startups (2178)
United States (10607)
Vaccines (608)
Weight loss (215)
Date
Today (141)
Last 7 days (652)
Last 30 days (1528)
Last 365 days (24542)
2025 (908)
2024 (24704)
2023 (27827)
2022 (36713)
2021 (39422)
2020 (37443)
2019 (30958)
2018 (23490)
2017 (22414)
2016 (20800)
2015 (24013)
2014 (18201)
2013 (14738)
2012 (15641)
2011 (16471)
2010 (14942)
Location
Africa (617)
Arizona (95)
Asia (28436)
Australia (4925)
California (2767)
Canada (1069)
China (276)
Colorado (125)
Connecticut (121)
Europe (66615)
Florida (384)
Georgia (98)
Illinois (254)
Indiana (185)
Maryland (554)
Massachusetts (2006)
Michigan (92)
Minnesota (126)
New Jersey (855)
New York (830)
North Carolina (473)
Northern California (1301)
Ohio (99)
Pennsylvania (612)
South America (859)
Southern California (1040)
Texas (357)
Washington State (288)
438,344 Results for "roche holding ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings’ Catalent Buyout
Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by strong performance of its multiple sclerosis therapy Ocrevus and eye injection Vabysmo.
October 23, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Antibody drug conjugate
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.
January 2, 2025
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
Roche Nears Completion of Poseida Acquisition Worth Up to $1.5B
In a deal expected to close in Q1 2025, Roche will gain access to Poseida’s off-the-shelf CAR T candidates.
January 8, 2025
·
3 min read
·
Tristan Manalac
Immunology & inflammation
Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M
The collaboration will see COUR and Roche’s Genentech leverage the biotech’s antigen-specific immune tolerance platform to develop and commercialize therapies for an undisclosed autoimmune disease.
December 3, 2024
·
1 min read
·
Heather McKenzie
Weight loss
Roche’s Obesity Pill Candidate Hit With Safety Concerns Despite Strong Efficacy Data
When doses were increased rapidly in a Phase I study, patients on Roche’s investigational oral GLP-1 receptor agonist experienced nausea, vomiting, constipation, diarrhea, as well as abdominal distension.
September 12, 2024
·
2 min read
·
Tristan Manalac
Policy
Funding secured for CE approval of the groundbreaking C-MIC device from Berlin Heals Holding AG
The Berlin Heals Holding AG has developed the C-MIC device, a revolutionary and life-saving treatment for patients with heart failure.
June 17, 2024
·
2 min read
Regulatory
Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall
Roche’s eye implant Susvimo for patients with neovascular age-related macular degeneration is re-entering the U.S. market after the FDA approved updates to the components of the product.
July 9, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease.
October 22, 2024
·
1 min read
·
Annalee Armstrong
Business
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.
June 14, 2024
·
4 min read
1 of 43,835
Next
